WESTBOROUGH, Mass.--(BUSINESS WIRE)--GenomeQuest Inc., a global provider of large-scale genomic software applications, today announced the availability of the industry’s first clinical decision-support system for whole-genome diagnostics. Used to analyze and report information about variations and changes in genes and proteins to improve disease treatment, the GQ-DxSM product will launch immediately for the scientific and clinical communities seeking practical and efficient ways to translate advances from whole-genome sequencing into clinical application. GQ-Dx, based on the company's GQ-Engine, provides comprehensive genomic information capabilities at clinical scale, including:
